News (75)

Transcript : Aadi Bioscience, Inc., Q1 2024 Earnings Call, May 08, 2024
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO) PR
Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa PR
Transcript : Aadi Bioscience, Inc. - Special Call
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations PR
Transcript : Aadi Bioscience, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Transcript : Aadi Bioscience, Inc., Q2 2023 Earnings Call, Aug 09, 2023
Transcript : Aadi Bioscience, Inc., Q1 2023 Earnings Call, May 10, 2023
Transcript : Aadi Bioscience, Inc., Q4 2022 Earnings Call, Mar 28, 2023
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology Annual Meeting on Women's Cancer AQ
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer PR
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society 2022 Annual Meeting AQ
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting PR
Transcript : Aadi Bioscience, Inc., Q3 2022 Earnings Call, Nov 09, 2022
Transcript : Aadi Bioscience, Inc., Q2 2022 Earnings Call, Aug 10, 2022
Aadi Bioscience : Corporate Overview PU
Aadi Bioscience : Corporate Overview PU
Transcript : Aadi Bioscience, Inc., Q1 2022 Earnings Call, May 12, 2022
Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders AQ
Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2 Registrational Trial of nab-Sirolimus in Patients with Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 and TSC2 Genes AQ
AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) AQ
Aadi Bioscience : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - Form 8-K PU
Aadi Bioscience : Corporate Overview PU
Aadi Bioscience : Corporate Overview PU
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update - Form 8-K PU
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update AQ
Aadi Bioscience : Appoints Loretta Itri as Chief Medical Officer AQ
Aadi Bioscience, Inc. Appoints Loretta Itri as Chief Medical Officer CI
Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer AQ
Gilead Sciences : Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast Cancer BU
Immunomedics : Announces FDA Orphan Drug Designation of Trodelvyᵀᴹ for Glioblastoma PU
Immunomedics : Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma AQ
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma GL
Transcript : Immunomedics, Inc. - Special Call
Immunomedics : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvyᵀᴹ in Metastatic Urothelial Cancer PU
Immunomedics : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer AQ
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer GL
Immunomedics : Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer AQ
Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer GL
Immunomedics : Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers AQ
Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers GL
Transcript : Immunomedics, Inc., Q2 2020 Earnings Call, Aug 05, 2020
Immunomedics : Expands Collaboration with Roche Evaluating TrodelvyTM PU
Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers GL
12NextSee all

Companies (2)

MERCHANT HOUSE INTERNATIONAL LIMITED 4 M $
Logo Merchant House International Limited

Merchant House International Limited is a designer, manufacturer and marketer of leather boots and shoes, home and seasonal decorative items, and home textile. The Company operates in four segments: Home textile manufacturing, Home textile trading, Footwe ...

VMS INDUSTRIES LIMITED 7 M $
Logo VMS Industries Limited

VMS Industries Limited is an India-based company, which is engaged in the business of ship breaking as well as trading in ferrous and non-ferrous metals. The Company's segments include Manufacturing and Trading. The Manufacturing segment is engaged in shi ...


Insiders

Picture Loretta Itri
Loretta Itri

Loretta M. Itri is Chief Medical Officer of Immunomedics, Inc. In the past she held the position of Chief Medical Officer at Genta, Inc., Senior Vice President-Medical & Regulatory Affairs at Robert Wood Johnson Pharmaceutical Research Institute, Chief Medical Officer & Senior VP-Clinical Affairs at Ortho Biotech Products LP, Senior Director-Clinical Investigations at Hoffmann-La Roche, Inc., EVP-Global Health Science & Regulatory Affairs at The Medicines Co. and Member-Scientific Counselor at National Cancer Institute. Dr. Itri received a doctorate from New York Medical College and an undergraduate degree from Long Island University.


Picture Loretta Marcoccia
Loretta Marcoccia

Loretta Marcoccia holds the position of Chief Operating Officer & EVP-Global Banking at The Bank of Nova Scotia. Ms. Marcoccia is also on the board of Women in Capital Markets. She received an undergraduate degree from the University of Toronto.


Picture Loretta Cecil
Loretta Cecil

Loretta A.
Cecil
is currently the Director at GenapSys, Inc. and a Member at The Phi Beta Kappa Society.
She previously worked as the Senior Vice President-Governance Relations at McKesson Corp., Chief Compliance Officer & General Counsel at NCR Voyix Corp., and General Counsel at Mckesson Technology Solutions.
She was also a Member at Womble Bond Dickinson (US) LLP.
From 2017 to 2022, she served as the Executive Vice President & General Counsel at Change Healthcare, Inc. Ms. Cecil holds a graduate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from The University of North Carolina at Greensboro.


Picture Loretta Yuen
Loretta Yuen

Loretta Yuen occupies the position of EVP, Head-Group Legal & Regulatory Compliance at Oversea-Chinese Banking Corp. Ltd. She received a graduate degree from National University of Singapore.






Picture Lorettta M. Itri
Lorettta M. Itri

Lorettta M.
Itri
currently works as a Director at The American-Italian Cancer Foundation.



Picture Rich Itri
Rich Itri

Rich Itri currently works as a Director & Chief Innovation Officer at Eze Castle Integration, Inc.












Picture Loretta Martin
Loretta Martin

Loretta Martin is currently working as the Vice President-Operations at createTank LLC since 2003.
She completed her undergraduate degree from West Virginia University in 1984.


Picture Loretta Young Walker
Loretta Young Walker

Ms. Loretta Y.
Walker is Chief Human Resources Officer & SVP at Turner Broadcasting System, Inc. and Secretary & Director at Cancer Treatment Centers of America, Inc. She is on the Board of Directors at Southeastern Regional Medical Center, Atlanta Housing Authority (Georgia) and Cancer Treatment Centers of America, Inc. Ms. Walker also served on the board at PRIDE Industries, Inc.


Picture Loretta Polk
Loretta Polk

Loretta Polk has a current job as the General Counsel at NCTA - The Internet & Television Association.


Picture Loretta Brennan Glucksman
Loretta Brennan Glucksman

Loretta Brennan Glucksman is currently the Chairman-Emeritus of The American Ireland Fund.


Picture Loretta Minghella
Loretta Minghella

Loretta Minghella is currently a Director at the Banking Standards Board.
Previously, she was the Chief Executive Officer at Christian Aid.





Picture Loretta Jacobs
Loretta Jacobs

Loretta Jacobs is a Member of The American Academy of Actuaries, and a former Vice President-Long Term Care at Bankers Life & Casualty Co. She obtained an undergraduate degree from the University of Notre Dame.


Picture Loretta Jones
Loretta Jones

Loretta Jones worked as a Principal at CrossWorlds Software, Inc., Coveo Solutions, Inc., and Lotus, Inc. She also worked as Head-Marketing at EchoSign, Inc. Jones received an undergraduate degree from Brown University.





Picture Loretta Chen
Loretta Chen

Ms. Chen joined Venrock in 2008 and brings 6 years of finance and accounting experience to the position.
Previously, she a was Fund Accounting Supervisor at Citco, a hedge fund administration services provider.
Prior to Citco, Ms. Chen contributed at HSBC and UBS Global Asset Management.
Loretta has a Bachelor of Business Administration degree from the University of Toronto and is a Certified Management Accountant (CMA).





Picture Loretta Credaro
Loretta Credaro

Loretta Credaro currently works at Banca Popolare di Sondrio SPA, as Executive Director from 2015 and Sondrio Servizi Al Terziario Srl, as President.


Picture Loretta Bu
Loretta Bu

Loretta Bu worked as a Strategist at Citigroup Global Markets, Inc. from 2014 to 2019.
Prior to that, she obtained an undergraduate degree from Duke University.



Picture Loretta Moseman
Loretta Moseman

Loretta Moseman currently works as a Treasurer & Trustee for Cancer Care, Inc.






Picture Loretta M. Plamondon
Loretta M. Plamondon

Loretta M.
Plamondon
is currently working as a Principal at TMW Enterprises, Inc.



Picture Loretta J. Mueller
Loretta J. Mueller

Loretta J.
Mueller
worked as the Chief Marketing Officer & Senior Vice President at BankAnnapolis from 1990 to 2013.





Picture Loretta Sanchez
Loretta Sanchez

Loretta L.
Sanchez
is currently the Chief Executive Officer of Datamatica LLC, an Independent Director at Universal Technical Institute, Inc., a Director at the Congressional Hispanic Caucus Institute, a Director at Career Education Colleges & Universities, and a Trustee at Chapman University.
She holds a Master's in Business Administration from American University and an undergraduate degree from Chapman University.


Picture Loretta A. Preska
Loretta A. Preska

Loretta A.
Preska
currently works at Fordham University, as Trustee.














Picture Loretta Chan
Loretta Chan

Loretta Chan has worked as a Marketing Director at Youth Communication since 2005.



Picture Loretta Ghelfi
Loretta Ghelfi

Loretta Ghelfi is currently a Senior Director at Cassa di Risparmio in Bologna SpA.
She previously held positions as Vice Chairman at Camera di Commercio Industria Artigianato Agricoltura Bologna and Director at Tecno Holding SpA.






Picture Loretta Everett Kaufman
Loretta Everett Kaufman

Loretta Everett Kaufman currently works as a Director at Geffen Playhouse.


Picture Loretta C. Galang
Loretta C. Galang

Loretta C.
Galang
currently works at Fortune Life Insurance Co., Inc., as Director.











Picture Loretta Jennings
Loretta Jennings

Loretta Jennings currently works as a Director & Co-Vice President at The Aids Alliance for Children Youth & Families.


Picture Loretta Cataldi
Loretta Cataldi

Loretta Cataldi has a current job as an Associated Broker at The Shopping Center Group LLC since 2016.



Picture Loretta Gladue
Loretta Gladue

Loretta Gladue currently works as a Trustee for Northland School Division 61.


Picture Loretta Anne Rogers
Loretta Anne Rogers

Loretta Anne Rogers served as a Director for various Rogers companies, including Rogers Cable, Rogers Wireless, Rogers Media, and Rogers Telecommunications Ltd.
She was also a Director for E.S.R Holdings Ltd.
and RT Holdings Ltd.
Additionally, she served as a Director for Sheena's Place, and as President for The Canadian Lyford Cay Foundation.
Rogers was a Member for Toronto General & Western Hospital Foundation, University Health Network Foundation, and Bateman Foundation.
She received an undergraduate degree from the University of Miami.


Picture Loretta R. Cross
Loretta R. Cross

Loretta R.
Cross
is currently the CEO, Director & Chief Restructuring Officer at Transferre Technologies, Inc. and also serves as a Director at The Greater Houston Women's Chamber of Commerce.
She completed her undergraduate degree at The University of Texas at Austin.






Picture Loretta Wedge
Loretta Wedge

Loretta M.
Wedge
is currently the Managing Partner at Semper Fi Accounting Services LLC.
Prior to her current position, she was the Independent Director at Biofrontera, Inc. from 2021 to 2023, Vice President & Controller at CRISPR Therapeutics, Inc. from 2015 to 2017, and Vice President-Finance & Controller at Velcro Ip Holdings LLC in 2017.
Ms. Wedge holds an MBA from California State University-Sacramento.



Picture Loretta Choy
Loretta Choy

Loretta Choy currently works as the Chief Merchandising Officer at Stitch Fix, Inc.




No results for this search